Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romosozumab vs. Zoledronic Acid in SCI and Low BMD
NCT04597931Phase 4Unknown
- Sponsor
- Sheba Medical Center
- Start
- Nov 2020
- Primary completion
- Nov 2023
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of romosozumab in osteoporosis, sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
romosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04597931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04597931.